8049 — Jilin Province Huinan Changlong Bio-pharmacy Co Share News
0.000.00%
- HK$1.39bn
- HK$607.56m
- CNY901.87m
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Announces Subscriptions Of Wealth Management Products
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Says Co Subscribed To Wealth Management Product
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Updates On Purchase Of ICBC Wealth Management Product
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes For Wealth Management Products
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Co Subscribes For Wealth Management Product Of Rmb20 Mln
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes For Wealth Management Product
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Posts Qtrly Profit Attributable Of RMB36.379 Mln
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Says Co Subscribed For Wealth Management Product For RMB30 Mln
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Co Subscribes For Wealth Management Products
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Says Subscribed For Wealth Management Products
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes For Wealth Management Product
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribed Wealth Management Products
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes For Wealth Management Product In Amount Of Rmb40 mln
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Announces Subscription Of Wealth Management Product
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Posts Qtrly Profit Attributable Of RMB36.6 Mln
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Updates on Wealth Management Products Subscriptions
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Posts Qtrly Profit Attributable RMB18.9 Million
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Co Appoints Executive Directors
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Co Says FY Revenue RMB645.3 Mln